Clinical ink, a global life science technology company, announces the promotion of John Pappadakis from EVP, Global Business Development to Chief Commercial Officer and Megan Petrylak from EVP, Clinical Operations to Chief Operating Officer.
GlucoseReady™: Diabetes
Delivers CGM/BGM, eCOA and Behavioral management
for diabetes trials
for diabetes trials
GlucoseReady™:
Weight Management/NASH
eCOA + Behavioral management for obesity trials
WEBINAR ON DEMAND
How Patient-Centered Technologies Can Elevate Diabetes Clinical Trials to Align with Current Standards of Care
Our panel of clinical experts addresses the recent FDA guidance on continuous glucose monitoring (CGM).
Reduce your Study Build Timeline to 10 Days
Innovative eCOA technology sets new standard for speed, efficiency, and accuracy in study build process. Read the press release.
Nature Magazine Publishes Work Demonstrating Clinical ink Technology Sensitivity to Parkinson’s Disease
COA vs. eCOA Cost Calculator
Get your study-specific cost comparison between paper COA and eCOA within 48 hours. See how much you can save today.
Breakthrough Evidence with Digital Biomarkers in Movement Disorders
See how we successfully demonstrated disease status and treatment response for clinical development and medical practice.
Clinical ink is leading the way to recenter decentralized clinical trials by connecting data and operations.
At the core of our clinical trial solutions is the Clinical ink eSource ecosystem, designed to ingest all incoming data into a unified data platform that supports analytics within and across studies, regardless of how it was captured or by whom.
A Better eSource Solution
Clinical ink’s eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas.
The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.
Lorem Ipsum sit Amet Dolor
Clinical ink’s eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas.
The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.
0
+
Studies
0
+
Assessments
and Instruments
and Instruments
0
+
BYOD Studies
1
M+
Cognitive and Behavioral Measures
0
+
Sponsors and CROs
eSource Technology
eCOA
Minimize complexity, accelerate study build, and cover therapeutic areas via fit-for-purpose assessments.
DDC Technology
Capture directly and validate data, documents, audio, images, and video in real time.
eConsent
Simplify and speed study startup, standardize processes, and empower patients.
eLAS® Suite
Facilitate lupus trials with straightforward, efficient, and reliable direct data capture.
Mobile Devices
Deliver reach, efficiency, and data quality, while increasing patient engagement.
Televisit
Benefit from an easy, efficient, holistic telehealth solution and improve remote monitoring.
Sensors & Wearables
Enrich advanced clinical trial data collection with a variety of sensors and wearables solutions.
Digital Biomarkers
Validate measurements from sensors, algorithms, and deliver clinical data in real-time.
See everything our eSource technology platform has to offer.
eSource technologies improve the efficiency and reduce the cost of clinical trials, particularly in the context of complex therapeutic areas.
The depth and breadth of our therapeutic experience – across neurology, infectious disease, immunology, and oncology – means you get the expertise and improved results for your clinical research.
Neurology
Improve results for complex clinical trials involving central nervous system conditions.
Infectious Disease
Speed up trial timelines and improve the data quality of your infectious disease studies.
Immunology
Leverage eSource tools to simplify and improve outcomes in complex Lupus clinical trials.
Oncology
Deliver on the Enhancing Oncology Model and improve patient adherence throughout the trial.
Diabetes
Offer a better patient experience and improve trial outcomes for diabetes research.
Immunology
Leverage eSource tools to simplify and improve outcomes in complex Lupus clinical trials.
Infectious Disease
Speed up trial timelines and improve the data quality of your infectious disease studies.
Neurology
Improve results for complex clinical trials involving central nervous system conditions.
Neurology
Improve results for complex clinical trials involving central nervous system conditions.
Oncology
Deliver on the Enhancing Oncology Model and improve patient adherence throughout the trial.
